Clinical Trial Update: Body Weight Adjusted Clopidogrel Treatment in Patients With CORonary Artery Disease [Phase 2, Phase 3]

View source ↗

Summary

A clinical trial update exploring body weight–adjusted clopidogrel treatment in coronary artery disease patients, spanning Phase 2 and Phase 3.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Artery Disease

Drugs mentioned

• CLOPIDOGREL (CLOPIDOGREL)

Snippet

Sponsor: St. Antonius Hospital | Conditions: Coronary Artery Disease, Platelet Reactivity | Phase 2, Phase 3 | Status: UNKNOWN